En Carta Diagnostics secured €1.5 million in pre-seed funding led by CentraleSupélec Venture to advance platform for early Lyme disease detection
En Carta Diagnostics secured €1.5 million in pre-seed funding led by CentraleSupélec Venture to advance platform for early Lyme disease detection
05/22/24, 10:06 AM
Location
parisMoney raised
€1.5 million
Industry
health diagnostics
biotechnology
health care
Round Type
seed
Investors
High Profile Business Angels, Centrale Supélec Venture
En Carta Diagnostics, a startup specializing in rapid Point-of-Care molecular diagnostics, has announced the completion of a €1.5 million pre-seed funding round. This investment will be utilized to further the development of a prototype diagnostic kit for early Lyme disease detection and to facilitate scalability.